EVAX•benzinga•
Evaxion Completes Dosing In Phase 2 Trial With Personalized Cancer Vaccine EVX-01; Trial Remains On Track For Completion And Data Readout In The Second Half Of 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 15, 2025 by benzinga